Corpus Intelligence IC Memo — COPPER QUEEN COMM. HOSP. 2026-04-26 15:02 UTC
IC Memo — COPPER QUEEN COMM. HOSP.
Investment Committee Memorandum | AZ | 14 beds | Grade C | EBITDA uplift $4.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COPPER QUEEN COMM. HOSP.

CCN 031312 | COCHISE, AZ | 14 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COPPER QUEEN COMM. HOSP. is a 14-bed suburban community hospital in COCHISE, AZ with $63.5M in net patient revenue and a 6.6% operating margin. The hospital serves a payer mix of 25.0% Medicare, 9.0% Medicaid, and 66.1% commercial.

Thesis: Turnaround. Our ML models identify $4.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.6% to 14.0% (+736bps).

Net Revenue HCRIS$63.5M
Current EBITDA COMPUTED$4.2M
Operating Margin COMPUTED6.6%
Occupancy HCRIS34.5%
Revenue / Bed COMPUTED$4.5M
Net-to-Gross HCRIS26.0%
Distress Probability ML47.2%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
27
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 6.6% places it above the state median. Among 27 size-comparable peers (7-28 beds), the median margin is -5.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (7-28), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COPPER QUEEN COMM. HOSP. (Target)AZ14$63.5M6.6%
ARIZONA GENERAL HOSPITALAZ16$97.1M10.4%
THE CORE INSTITUTE SPECIALTY HAZ28$91.2M9.2%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$75.2M-2.8%
COBRE VALLEY REG. MEDICAL CENTAZ25$74.9M-10.3%
MT. GRAHAM REGIONAL MEDICAL CEAZ25$49.4M-6.8%
BANNER PAYSON MEDICAL CENTERAZ25$49.3M0.0%
AZ SPINE & JOINT HOSPITALAZ23$45.1M19.4%
WINSLOW MEMORIAL HOSPITALAZ25$40.1M-6.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$773K+122bp9mo
Clean Claim Rate88.0%96.0%$41K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$773K
Clean Claim Rate
$41K
Total EBITDA Uplift$4.7M
Current EBITDA$4.2M
+ RCM Uplift+$4.7M
Pro Forma EBITDA$8.9M
Current Margin6.6%
Pro Forma Margin14.0%
WC Released (1x)$2.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.5M$74.5M11.51x63.0%
Base (11x exit)10.0x11.0x$6.5M$84.0M12.99x67.0%
Bull Case9.0x11.0x$5.8M$101.6M17.44x77.1%
Bull (12x exit)9.0x12.0x$5.8M$112.5M19.32x80.8%
Bear Case11.0x10.0x$7.1M$49.0M6.89x47.1%
Bear (11x exit)11.0x11.0x$7.1M$56.2M7.90x51.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 34.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 7-28 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-11.1% / P50=-5.5% / P75=0.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.